G. Coppola

Publications186
h-index38
Citations4,118
Highly Influential Citations166
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Verrotti
  • 635 Publications, 11,162 Citations
  • I. Scheffer
  • 568 Publications, 43,245 Citations
  • S. Berkovic
  • 758 Publications, 54,655 Citations
  • R. Pierantoni
  • 177 Publications, 3,595 Citations
  • Publications
  • Influence
The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience
PURPOSE This collaborative study by three Italian groups of child neuropsychiatrists was carried on to evaluate the efficacy and safety of the classic 4:1 ketogenic diet as add-on treatment in… Expand
  • 132
  • 7
Lamotrigine versus Valproic Acid as First‐line Monotherapy in Newly Diagnosed Typical Absence Seizures: An Open‐label, Randomized, Parallel‐group Study
Summary:  Purpose: To compare the efficacy of lamotrigine (LTG) and valproic acid (VPA) in newly diagnosed children and adolescents with typical absence seizures.
  • 115
  • 7
Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial
To evaluate the efficacy and tolerability of levetiracetam or oxcarbazepine as monotherapy in children with newly diagnosed benign epilepsy with centrotemporal spikes (BECTS). Twenty-one children (11… Expand
  • 69
  • 7
Malignant migrating partial seizures in infancy: An epilepsy syndrome of unknown etiology
The syndrome of malignant migrating partial seizures in infancy was first reported in 1995, and is now included among the childhood epilepsy syndromes in development in the proposal of the revision… Expand
  • 88
  • 6
Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications
In the last years, a growing body of literature indicates an association between valproic acid therapy and weight gain. Weight gain during valproate treatment can be observed within the first 3… Expand
  • 87
  • 5
The metabolic syndrome in overweight epileptic patients treated with valproic acid
Purpose:  To evaluate the presence of metabolic syndrome (MS) in children and adolescents treated with valproate (VPA).
  • 89
  • 5
Efficacy and safety of levetiracetam: An add-on trial in children with refractory epilepsy
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and safety of levetiracetam in 110 children with refractory epilepsy, of whom 21 were less than 4 years… Expand
  • 71
  • 5
A multicenter, randomized, placebo‐controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy
Purpose:  To evaluate the potential efficacy of levetiracetam as an antiabsence agent in children and adolescents with newly diagnosed childhood or juvenile absence epilepsy.
  • 52
  • 5
Neuropsychological impairment in children with Rolandic epilepsy and in their siblings
To assess and characterize a possible neurocognitive endophenotype associated with Rolandic epilepsy (RE), a clinical study was carried out to evaluate the neuropsychological profile of children with… Expand
  • 30
  • 5
Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy
Purpose:  The present study aimed to assess bone mineral density (BMD) in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy.
  • 26
  • 5